Pamela Pavco
2013 - RXi Pharmaceuticals
In 2013, Pamela Pavco earned a total compensation of $692.2K as Chief Development Officer at RXi Pharmaceuticals, a 65% decrease compared to previous year.
Compensation breakdown
| Bonus | $103,500 |
|---|---|
| Option Awards | $264,001 |
| Salary | $324,404 |
| Other | $300 |
| Total | $692,205 |
Pavco received $324.4K in salary, accounting for 47% of the total pay in 2013.
Pavco also received $103.5K in bonus, $264K in option awards and $300 in other compensation.
Rankings
In 2013, Pamela Pavco's compensation ranked 8,176th out of 12,286 executives tracked by ExecPay. In other words, Pavco earned more than 33.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,176 out of 12,286 | 34th |
Division Manufacturing | 2,959 out of 4,612 | 36th |
Major group Chemicals And Allied Products | 921 out of 1,462 | 37th |
Industry group Drugs | 698 out of 1,156 | 40th |
Industry Pharmaceutical Preparations | 553 out of 890 | 38th |
Source: SEC filing on April 16, 2015.
Pavco's colleagues
We found one more compensation record of an executive who worked with Pamela Pavco at RXi Pharmaceuticals in 2013.
2013
Geert Cauwenbergh
RXi Pharmaceuticals